PAR paradigm biopharmaceuticals limited..

Ann: PAR Successful Placement and Fully Underwritten ANREO, page-5

  1. 3,859 Posts.
    lightbulb Created with Sketch. 1629
    The irony is that if he raised another $65m back then we would have had a total of 335m shares on issue.

    Post this cap raise, we will have 350m shares, plus another 63m options if they are converted. so 413m shares. Or in % terms another 23% of dilution.

    The options aren’t even guaranteed at this point, as we still don’t have enough money to finish off the phase III, it’s relying on us converting options at a higher price. Why would the price go higher if we weren’t guaranteed the money to finish our phase III? Only possible reason is if we have a deal signed up for approximately $30m plus.

    $30m plus eh? 40% returns CAGR? These figures are the performance hurdles to secure the rights of PR and Donna. Talk about taking the owners of the company for a ride!

    I recently read an article about the average salary of an ASX200 listed company being $1.2m. We have 2 employees wanting to be paid that. In PR’s case he’s looking at a 100% pay increase for his total package. It just gets more and more disgusting when I delve deeper into the PAR books.
    Last edited by slura: 31/10/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.005(1.20%)
Mkt cap ! $166.9M
Open High Low Value Volume
42.0¢ 43.0¢ 42.0¢ $117.7K 277.1K

Buyers (Bids)

No. Vol. Price($)
2 13178 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 17422 2
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.